Creating Optimism in Managing Chronic Obstructive Pulmonary Disease
Article Outline
Guest Editors
Robert A. Wise, MD
Professor of Medicine, Division of Pulmonary and Critical Care Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Donald P. Tashkin, MD
Professor of Medicine, Division of Pulmonary, Critical Care Medicine, and Hospitalists
David Geffen School of Medicine at UCLA
University of California–Los Angeles
Los Angeles, California
This supplement is based on the educational program Creating Optimism in Managing Pulmonary Disease, developed by a team of nationally known opinion leaders in the field of pulmonary disease to raise awareness and dispel misperceptions about chronic obstructive pulmonary disease (COPD). The program—which consists of live events, a dedicated Web site, print material, and e-newsletters—is based on scientific and clinical evidence and is intended for an audience of primary care physicians and community-based pulmonologists. This program, presented by The Johns Hopkins University School of Medicine, is supported by an unrestricted educational grant provided by Boehringer Ingelheim Pharmaceuticals, Inc., and Pfizer Inc. Editorial support was provided by Health Learning Systems (HLS; part of CommonHealth), Parsippany, New Jersey.
Statement of Peer Review: All supplement manuscripts submitted to The American Journal of Medicine for publication are reviewed by the Guest Editor(s) of the supplement, by an outside peer reviewer who is independent of the supplement project, and by the Journal’s Supplement Editor (who ensures that questions raised in peer review have been addressed appropriately and that the supplement has an educational focus that is of interest to our readership).
Author Disclosure Policy: All authors contributing to supplements in The American Journal of Medicine are required to fully disclose any primary financial relationship with a company that has a direct fiscal or financial interest in the subject matter or products discussed in the submitted manuscripts, or with a company that produces a competing product. These relationships (e.g., ownership of stock or significant honoraria or consulting fees) and any direct support of research by a commercial company must be indicated on the title page of each manuscript. This information will be published in the frontmatter of each supplement.
Editor-in-Chief: Joseph S. Alpert, MD
Editor, Supplements: William H. Frishman, MD
Publishing Director: Pamela Poppalardo
Executive Supplements Editor: Brian Jenkins
Senior Production Editor: Mickey Kramer
Proof/Production Editor: Mary Crowell
PII: S0002-9343(07)00568-2
doi:10.1016/j.amjmed.2007.06.013

